tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PYXS Stock Latest News

Pyxis Oncology Highlights Strategic Focus on Lead Candidate
Company AnnouncementsPyxis Oncology Highlights Strategic Focus on Lead Candidate
10d ago
8K
PYXS
Optimistic Buy Rating for Pyxis Oncology Amid Strategic Focus and Promising Drug Developments
PremiumRatings
Optimistic Buy Rating for Pyxis Oncology Amid Strategic Focus and Promising Drug Developments
13d ago
PYXS
Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus
PremiumRatings
Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus
15d ago
PYXS
Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology
PremiumRatings
Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology
15d ago
PYXS
Pyxis Oncology Advances Cancer Therapeutics with MICVO
PremiumCompany Announcements
Pyxis Oncology Advances Cancer Therapeutics with MICVO
15d ago
PYXS
Pyxis Oncology Announces CMO Resignation and New Trials
PremiumCompany AnnouncementsPyxis Oncology Announces CMO Resignation and New Trials
16d ago
8K
PYXS
Pyxis Oncology reports FY24 EPS ($1.32), consensus ($1.09)
Premium
The Fly
Pyxis Oncology reports FY24 EPS ($1.32), consensus ($1.09)
16d ago
PYXS
PYXS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PYXS Upcoming Earnings Report: What to Expect?
16d ago
PYXS
Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy
PremiumThe Fly
Pyxis Oncology granted Fast Track designation for PYX-201 monotherapy
1M ago
PYXS
Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions
PremiumThe Fly
Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions
2M ago
MRK
PYXS
Pyxis Oncology price target lowered to $5 from $7 at H.C. Wainwright
PremiumThe Fly
Pyxis Oncology price target lowered to $5 from $7 at H.C. Wainwright
3M ago
PYXS
Pyxis Oncology price target lowered to $8 from $10 at RBC Capital
PremiumThe Fly
Pyxis Oncology price target lowered to $8 from $10 at RBC Capital
3M ago
PYXS
Pyxis Oncology to prioritize PYX-201, suspends investment in PYX-106
PremiumThe FlyPyxis Oncology to prioritize PYX-201, suspends investment in PYX-106
3M ago
PYXS
RBC ups Pyxis Oncology target, says buy shares on selloff
Premium
The Fly
RBC ups Pyxis Oncology target, says buy shares on selloff
4M ago
PYXS
Pyxis Oncology reported ‘compelling’ cancer dataset, says H.C. Wainwright
Premium
The Fly
Pyxis Oncology reported ‘compelling’ cancer dataset, says H.C. Wainwright
4M ago
PYXS
Pyxis Oncology downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Pyxis Oncology downgraded to Market Perform from Outperform at William Blair
4M ago
PYXS
Closing Bell Movers: Nvidia down slightly after Q3 results
PremiumThe Fly
Closing Bell Movers: Nvidia down slightly after Q3 results
4M ago
CPA
DFH
Pyxis Oncology Reports Promising Phase 1 Trial Results
PremiumCompany Announcements
Pyxis Oncology Reports Promising Phase 1 Trial Results
4M ago
8K
PYXS
Pyxis Oncology announces preliminary PYX-201 data, collaboration with Merck
PremiumThe Fly
Pyxis Oncology announces preliminary PYX-201 data, collaboration with Merck
4M ago
MRK
PYXS
Pyxis Oncology reports Q3 EPS (35c), consensus (31c)
PremiumThe FlyPyxis Oncology reports Q3 EPS (35c), consensus (31c)
5M ago
PYXS
Pyxis Oncology sees cash runway into 2H26
Premium
The Fly
Pyxis Oncology sees cash runway into 2H26
5M ago
PYXS
Pyxis Oncology to host investor event to present preliminary PYX-201 data
Premium
The Fly
Pyxis Oncology to host investor event to present preliminary PYX-201 data
5M ago
PYXS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >